These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17263254)

  • 21. Therapy-refractory schizophrenia in a patient who previously suffered from Meige's syndrome.
    Uemura T; Mochida M; Matsumi T; Yoshimoto K; Tatebayashi Y
    Neuropsychopharmacol Rep; 2019 Dec; 39(4):297-300. PubMed ID: 31743613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dystonia as the cause of pharyngolaryngeal motility disorders].
    Zwirner P; Dressler D
    HNO; 1995 Aug; 43(8):498-501. PubMed ID: 7558908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete remission of neuroleptic-induced Meige's syndrome by botulinum toxin treatment: a case report.
    Kurata K; Kuze S; Shibata R; Hatakeyama N; Masuda A; Ito Y; Kurachi M
    Jpn J Psychiatry Neurol; 1993 Mar; 47(1):115-9. PubMed ID: 8105127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspects.
    Tolosa E; Martí MJ
    Adv Neurol; 1988; 49():73-84. PubMed ID: 3278555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia.
    Adams SG; Hunt EJ; Irish JC; Charles DA; Lang AE; Durkin LC; Wong DL
    J Otolaryngol; 1995 Dec; 24(6):345-51. PubMed ID: 8699600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unilateral versus bilateral botulinum toxin injections in spasmodic dysphonia: acoustic and perceptual results.
    Adams SG; Hunt EJ; Charles DA; Lang AE
    J Otolaryngol; 1993 Jun; 22(3):171-5. PubMed ID: 8371328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebellar degeneration and Meige's syndrome.
    Khara JS; Calabrese VP
    South Med J; 1991 Mar; 84(3):387-9. PubMed ID: 2000530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia.
    Langeveld TP; Drost HA; Baatenburg de Jong RJ
    Ann Otol Rhinol Laryngol; 1998 Apr; 107(4):280-4. PubMed ID: 9557760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spasmodic dysphonia.
    Rosenfield DB
    Adv Neurol; 1988; 50():537-45. PubMed ID: 3400508
    [No Abstract]   [Full Text] [Related]  

  • 30. Botulinum toxin injections for the treatment of spasmodic dysphonia.
    Watts CC; Whurr R; Nye C
    Cochrane Database Syst Rev; 2004; 2004(3):CD004327. PubMed ID: 15266530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tongue protrusion dystonia: treatment with botulinum toxin.
    Charles PD; Davis TL; Shannon KM; Hook MA; Warner JS
    South Med J; 1997 May; 90(5):522-5. PubMed ID: 9160072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors and demographics in patients with spasmodic dysphonia.
    Schweinfurth JM; Billante M; Courey MS
    Laryngoscope; 2002 Feb; 112(2):220-3. PubMed ID: 11889373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study.
    Jankovic J; Orman J
    Neurology; 1987 Apr; 37(4):616-23. PubMed ID: 3561773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meige's syndrome in dementia with Lewy bodies.
    Tabet N; Sivaloganathan S
    J R Soc Med; 2002 Apr; 95(4):201-2. PubMed ID: 11934913
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical features and factors related to the functional prognosis in Meige's syndrome].
    Kamitsukasa I; Yamada T; Tokumaru Y; Hirayama K
    Rinsho Shinkeigaku; 1995 Mar; 35(3):231-6. PubMed ID: 7614742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin treatment in clinical neurology.
    Van den Bergh P
    Acta Neurol Belg; 1995; 95(2):70-9. PubMed ID: 7618431
    [No Abstract]   [Full Text] [Related]  

  • 37. Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia.
    Bhattacharyya N; Tarsy D
    Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):389-92. PubMed ID: 11296046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Meige's or Brueghel's syndrome? A neurologic disease that is possible to treat].
    von Schéele C; Akerstedt AC
    Lakartidningen; 1989 Oct; 86(43):3676-8. PubMed ID: 2682090
    [No Abstract]   [Full Text] [Related]  

  • 39. Voice disorders in the workplace: productivity in spasmodic dysphonia and the impact of botulinum toxin.
    Meyer TK; Hu A; Hillel AD
    Laryngoscope; 2013 Nov; 123 Suppl 6():S1-14. PubMed ID: 23818277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Meige's syndrome associated with basal ganglia and thalamic functional disorders].
    Sakai T; Shikishima K; Kawai K; Kitahara K
    Nippon Ganka Gakkai Zasshi; 1998 Nov; 102(11):764-70. PubMed ID: 9852722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.